Chicago, IL, December 07, 2011 --(PR.com
)-- Conference leader Q1 Productions prepares to host its event* examining the challenges faced, strategies employed and future ahead for today’s pharmaceutical public relations professional. Held over January 30 and 31, 2012 in Cambridge, MA, this conference will bring together various insights from the likes of Pfizer, Bristol-Myers Squibb and Janssen Pharmaceuticals to speak to achieving the most effective brand communications in industry undertakings like product crisis management and corporate social responsibility.
As high-profile incidents within industry continue to make headlines, requiring the deft handling of pharmaceutical PR executives as they release and react to information, the stakes are only growing to distribute the best messages. Pharmaceutical companies are constantly strategizing to maintain and augment company reputation and investor relations. Additionally, the space opens into less explored and regulated territories like social media sites and other online resources in which expectations have yet to be conceptualized, requiring even more of today’s pharmaceutical communications executive. This conference seeks to make the most of these areas, utilizing both external communication and internal communication tactics. Because external and internal communications relay different messages to different company stakeholders, specific strategies must be employed in each arena. This conference will feature two separate tracks, exploring the issues associated with each type of corporate communication.
Q1’s Pharmaceutical PR & Corporate Communications Conference will address these concerns and more with both large and small, niche group sessions, panel discussions and informal, conversational networking opportunities. Industry leaders will join together to share their cutting-edge, successful strategies this winter at the event. For full details and/or registration, visit: Q1Productions.com/RxPRandCommunications
Presenting organizations include: Abbott Laboratories, Acorda Therapeutics, Alnylam Pharmaceuticals, Amag Pharmaceuticals, Amgen, Arnold & Porter LLP, Baxter, Bristol-Myers Squibb, Cephalon, Eli Lilly, EMD Serono, Genzyme, Janssen Pharmaceuticals, Millennium Pharmaceuticals, Mylan, Pfizer, Sanofi Pasteur, Shire Pharmaceuticals and Vertex Pharmaceuticals
Media Contact: Paul Hernandez
About the Organizer
Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences in order to provide strategic and timely information. Through a rigid production process focused on end-user research and design, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative issues, enhanced business processes or technologies that will drive efficiency and customer service, our programs provide solutions to the urgent needs of our attendees. Visit www.q1productions.com
*Event will be held jointly with Q1 Productions’ Medical Communications & the Dissemination of Scientific Information Conference.